INTELENCE ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
18脊髄小脳変性症(多系統萎縮症を除く。)1

18. 脊髄小脳変性症(多系統萎縮症を除く。)


臨床試験数 : 71 薬物数 : 101 - (DrugBank : 30) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 65
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2019-002618-38-IT
(EUCTR)
25/06/202001/06/2021Clinical trial - phase II - to test safety and efficay of Etravirine's treatment in FriedreichClinical trial - phase II - to test safety and efficay of Etravirine's treatment in Friedreich Ataxia's patients - FAEST Friedreich's ataxia
MedDRA version: 20.0;Level: PT;Classification code 10017374;Term: Friedreich's ataxia;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Trade Name: INTELENCE - 200 MG - COMPRESSA -USO ORALE - FLACONE (HDPE) 60 COMPRESSE
Product Name: INTELENCE
Product Code: [J05AG04]
INN or Proposed INN: ETRAVIRINA
ASSOCIAZIONE LA NOSTRA FAMIGLIA - SEZIONE SCIENTIFICA I.R.C.C.S. E.MEDEANULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
35Phase 2Italy